PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 137 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2014. The put-call ratio across all filers is 1.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $39,501,000 | -5.1% | 167,300 | -24.0% | 6.10% | -4.9% |
| Q4 2014 | $41,639,000 | -65.6% | 220,000 | -56.7% | 6.42% | -74.2% |
| Q3 2014 | $121,074,000 | +784.1% | 507,500 | +144.6% | 24.90% | +586.2% |
| Q2 2014 | $13,695,000 | -36.6% | 207,500 | 0.0% | 3.63% | -27.0% |
| Q1 2014 | $21,609,000 | +4.4% | 207,500 | +3.8% | 4.97% | -17.3% |
| Q4 2013 | $20,706,000 | – | 200,000 | – | 6.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
| Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
| Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
| Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
| GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
| Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
| Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
| ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |